Cargando…
Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
The increasing incidence of bacterial infections caused by multidrug-resistant (MDR) Gram-negative bacteria has deepened the need for new effective treatments. Antibiotic adjuvant strategy is a more effective and economical approach to expand the lifespan of currently used antibiotics. Herein, we un...
Autores principales: | Chen, Chen, Cai, Jinju, Shi, Jingru, Wang, Zhiqiang, Liu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400630/ https://www.ncbi.nlm.nih.gov/pubmed/37537267 http://dx.doi.org/10.1038/s42003-023-05173-7 |
Ejemplares similares
-
Daunorubicin resensitizes Gram-negative superbugs to the last-line antibiotics and prevents the transmission of antibiotic resistance
por: Cai, Jinju, et al.
Publicado: (2023) -
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
por: Sun, Hongzhe, et al.
Publicado: (2020) -
Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
por: Wang, Yuhang, et al.
Publicado: (2023) -
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020) -
Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)